CEREVEL THERAPEUTICS HOLDING (CERE) Stock Balance Sheet
NASDAQ:CERE - Nasdaq - US15678U1280 - Common Stock - Currency: USD
| MRQ (2024-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 320.44M | 416.46M | 136.50M | 193.00M | 383.60M | |||
| Marketable Securities | 525.86M | 574.50M | 755.50M | 372.70M | N/A | |||
| Receivables | 4.96M | 5.29M | 2.00M | N/A | N/A | |||
| Other Current Assets | 8.32M | 10.68M | 11.60M | 12.30M | 7.00M | |||
| Total Current Assets | 859.58M | 1.01B | 905.70M | 578.00M | 390.60M | |||
| Non-Current Assets | ||||||||
| PPE Net | 44.60M | 45.77M | 49.30M | 51.70M | 48.60M | |||
| Investments And Advances | 218.59M | 185.20M | 58.10M | 52.30M | N/A | |||
| Other Non-Current Assets | 4.58M | 5.39M | 4.80M | 6.90M | 6.10M | |||
| Total Non-Current Assets | 267.77M | 236.36M | 112.10M | 110.90M | 54.70M | |||
| TOTAL ASSETS | 1.13B | 1.24B | 1.02B | 688.90M | 445.30M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 71.75M | 79.15M | 61.40M | 30.90M | 24.30M | |||
| Accounts Payable | 10.84M | 11.86M | 10.10M | 11.30M | 5.00M | |||
| Other Current Liabilities | 1.52M | 1.17M | 1.10M | 400.00K | 300.00K | |||
| Total Current Liabilities | 84.10M | 92.18M | 72.60M | 42.50M | 29.50M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 337.92M | 337.42M | 335.50M | 33.50M | 0.00 | |||
| Other Non-Current Liabilities | 140.86M | 139.95M | 88.50M | 34.10M | 31.20M | |||
| Total Non-Current Liabilities | 478.78M | 477.37M | 424.00M | 67.70M | 31.30M | |||
| TOTAL LIABILITIES | 562.89M | 569.55M | 496.60M | 110.20M | 60.80M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -1.53B | -1.40B | -967.80M | -616.20M | -390.90M | |||
| Additional Paid In Capital | 2.10B | 2.07B | 1.49B | 1.20B | 775.40M | |||
| Common Shares | 18.00K | 18.00K | 0.00 | 0.00 | 0.00 | |||
| Other Shareholders' Equity | -1.09M | 1.77M | 3.10M | -1.00M | N/A | |||
| Shares Outstanding | 181.89M | 181.36M | 156.50M | 147.70M | 127.10M | |||
| Tangible Book Value per Share | 3.10 | 3.71 | 3.33 | 3.92 | 3.03 | |||
| Total Shareholders' Equity | 564.46M | 673.75M | 521.20M | 578.70M | 384.50M | |||
| TOTAL LIABILITIES AND EQUITY | 1.13B | 1.24B | 1.02B | 688.90M | 445.30M | |||
| Statistics | ||||||||
| Debt/Equity | 0.60 | 0.50 | 0.64 | 0.06 | N/A | |||
| Current Ratio | 10.22 | 10.92 | 12.48 | 13.60 | 13.24 | |||
| Return On Assets (ROA) | -40.85% | -34.81% | -34.54% | -32.71% | -33.30% | |||
| Return On Equity (ROE) | -81.58% | -64.24% | -67.44% | -38.94% | -38.56% | |||
All data in USD , ROIC based on taxRate of 0.21